[1] |
Kuzumoto K, Kubota N, Ishii K, et al. Successful cessation of transmitting healthcare--associated infections due to Burkholderia cepacia complex in a neonatal intensive care unit in a Japanese children’s hospital[J]. Eur J Med Res,2011,16(2):537-542.
|
[2] |
Liao CH, Chang HT, Lai CC,et al. Clinical characteristics and outcomes of patients with Burkholderia cepacia bacteremia in an intensive care unit[J]. Diagn Microbiol Infect Dis,2011,70(2):260-266.
|
[3] |
Denman CC, Robinson MT, Sass AM, et al. Growth on mannitol-rich media elicits a genomewide transcriptional response in Burkholderia multivorans that impacts on multiple virulence traits in an exopolysaccharide-independent manner[J]. Microbiology,2014,160(1):187-197.
|
[4] |
Savi D, De Biase RV, Amaddeo A, et al. Burkholderia pyrrocinia in Cystic Fibrosis Lung Transplantation: A Case Report[J]. Transplant Proc,2014,46(1):295-297.
|
[5] |
Tenover FC, Arbeit RD, Goering RV, et al. Interpreting Choromosomal DNA restriction patterns produced by pulsed-fieldgel-electrophoresis-criteria for bacterial train typing[J]. J Clin Microbiol,1995,33(1):2233-2239.
|
[6] |
Nair BM, Cheung KJ, Griffith A, et al. Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar Ⅲ (B. cenocepacia) [J]. J Clin Invest,2004,113(3):464-473.
|
[7] |
茅国峰. 洋葱伯克霍尔德菌医院感染及耐药机制的研究进展[J]. 中国消毒学杂志,2014,31(1):57-59.
|
[8] |
Rocha J, Popescu AO, Borges P, et al. Structure of Burkholderia cepacia UDP-Glucose dehydrogenase (UGD) BceC and role of Tyr10 in final hydrolysis of UGD thioester intermediate[J]. J Bacteriol,2011,193(15):3978-3987.
|
[9] |
Zlosnik JEA, Costa PS, Brant R, et al. Mucoid and nonmucoid Burkholderia cepacia complex bacteria in cystic fibrosis infections[J]. Am J Respir Crit Care Med,2011,183(5):67-72.
|
[10] |
梁洪, 吴灿权, 郑悦康, 等. 应用PFGE检测技术进行一起洋葱伯克霍尔德菌感染溯源[J]. 中国卫生检验杂志,2014,24(4):519-520.
|
[11] |
Ottaviano G, Staffieri C, Favaretto N, et al. Burkholderia cepacia complex isolation in non-polypoid chronic rhinosinusitis[J]. Am J Otolaryngol,2014,35(5):598-602.
|
[12] |
龙琴, 刘靳波. 细菌分子生物学分型技术研究进展[J]. 国际检验医学杂志,2015,36(10):1423-1425.
|
[13] |
苑广盈, 马全萍, 闻新棉, 等. REP, RAPD和PFGE方法志贺菌分子分型中的应用评价[J]. 中国卫生检验杂志,2015,25(4):548-550.
|
[14] |
杨朵, 李娜, 辛续丽, 等. 北京世纪坛医院亚胺培南耐药的肺炎克雷伯菌院内感染流行病学调查[J]. 重庆医学,2017,46(7):941-945.
|
[15] |
潘庭荣, 黄梅, 陈远平, 等. 肺炎链球菌血清学, PFGE型别与流行和耐药的关联性分析[J]. 检验医学与临床,2017,14(11):1547-1549.
|
[16] |
Souza Dias MB, Cavassin LG, Stempliuk V, et al. Multi-institutional outbreak of Burkholderia cepacia complex associated with contaminated mannitol solution prepared in compounding pharmacy[J]. Am J Infect Control,2013,41(11):1038-1042.
|
[17] |
丁洽烽, 黄林喜. 感染性休克211例临床特征分析[J]. 广东医学,2017,38(6):891-893.
|
[18] |
戚智冬. ICU内脑出血患者肺部物理治疗疗效评估. 哈尔滨医科大学学报,2016,50(1):78-80.
|
[19] |
诸葛璐,潘陈为,林巍, 等. 洋葱伯克霍尔德菌下呼吸道医院感染危险因素及耐药性分析[J]. 中华临床感染病杂志,2014,7(2):140-144.
|
[20] |
刘波, 单南冰. ICU危重患者APACHE Ⅱ评分变化率和临床预后的关系[J]. 内科急危重症杂志,2017,23(2):142-144.
|
[21] |
王擂, 刘淑丽, 姜翠华, 等. 导管相关血流感染与APACHE Ⅱ评分的相关性[J/CD]. 中华实验和临床感染病杂志(电子版),2015,9(6):31-33.
|
[22] |
Buroni S, Matthijs N, Spadaro F, et al. Differential roles of RND efflux pumps in antimicrobial drug resistance of sessile and planktonic Burkholderia cenocepacia cells[J]. Antimicro Agent Chem,2014,58(12):7424-7429.
|
[23] |
Jassem AN, Forbes CM, Speert DP. Investigation of aminoglycoside resistance inducing conditions and a putative AmrAB-OprM efflux system in Burkholderia vietnamiensis[J]. Ann Clin Microbiol Antimicrob,2014,13(1):2.
|
[24] |
张丽伟, 江淑芳, 刘惕, 等. 2013-2015年医院感染现患率趋势调查[J]. 中华医院感染学杂志,2016,26(21):4916-4919.
|
[25] |
Mann T, Ben-David D, Zlotkin A, et al. An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients[J]. Infection,2010,38(3):187-194.
|